<DOC>
	<DOC>NCT00386867</DOC>
	<brief_summary>This open-label, randomized study will compare the efficacy, safety, and acceptability of mifepristone 200 mg followed in 24-36 hours either by buccal (i.e., in the cheeks) or oral misoprostol 800 mcg for termination of pregnancy in women up to 63 days L.M.P.</brief_summary>
	<brief_title>A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>be willing and able to sign consent forms; be eligible for medical abortion according to clinicianâ€™s assessment; be willing to undergo a surgical completion if necessary; have ready and easy access to a telephone and emergency transportation; speak English, Spanish, or have a translator available to translate for all study procedures; and, agree to comply with the study procedures and visit schedule. Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass; IUD in place; Chronic renal failure; Concurrent longterm corticosteroid therapy; History of allergy to mifepristone, misoprostol or other prostaglandin; Hemorrhagic disorders or concurrent anticoagulant therapy; Inherited porphyrias; or Other serious physical or mental health conditions.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>medical abortion</keyword>
	<keyword>mifepristone</keyword>
	<keyword>misoprostol</keyword>
	<keyword>buccal administration</keyword>
</DOC>